Stereocontrolled preparation of a nonpeptidal (-)-spirobicyclic NK-1 receptor antagonist

被引:36
|
作者
Maligres, PE
Waters, MM
Lee, J
Reamer, RA
Askin, D
Ashwood, MS
Cameron, M
机构
[1] Merck & Co Inc, Merck Res Labs, Dept Proc Res, Rahway, NJ 07065 USA
[2] Merck & Co Inc, Merck Sharp & Dohme Res Labs, Dept Proc Res, Hoddesdon EN11 9BU, Herts, England
来源
JOURNAL OF ORGANIC CHEMISTRY | 2002年 / 67卷 / 04期
关键词
D O I
10.1021/jo0157472
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The synthesis of a spirobicyclic NK-1 receptor (Substance-P) antagonist I antipode is described. Retrosynthetic analysis reveals an allylic halide A bearing the cyclopropoxy-substituted aryl group and a 2-phenyl-3-piperidone B. The stereochemistry in the spirobicyclic system bearing three chiral centers is initially set via a highly diastereoselective zinc-mediated coupling of the allylic bromide 23 to the optically active ketopiperidine 3. The remaining benzylic asymmetric center is set by a diastereoselective hydroboration followed by cyclization to the spirobicyclic system.
引用
收藏
页码:1093 / 1101
页数:9
相关论文
共 50 条
  • [31] NK-1 receptor antagonist modulates Mg-deficiency (MgD)-induced myocardial inflammation.
    Phillips, TM
    Kramer, JH
    Weglicki, WB
    FASEB JOURNAL, 1996, 10 (03): : 1860 - 1860
  • [32] IS THE SELECTIVE NONPEPTIDE NK-1 RECEPTOR ANTAGONIST CP96,345 A PERIPHERALLY ACTING ANALGESIC
    BERGE, OG
    STAHLBERG, M
    REGULATORY PEPTIDES, 1992, : S36 - S36
  • [33] Tradipitant, a novel nk-1 receptor antagonist, significantly improved nausea in both diabetic and idiopathic gastroparesis
    Carlin, J. L.
    Keefe, M. S.
    Lieberman, V. R.
    Dahal, A.
    Xiao, C.
    Birznieks, G.
    Polymeropoulos, M. H.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [34] Anti-emetic effects of a novel NK-1 receptor antagonist HSP-117 in ferrets
    Saito, R
    Suehiro, Y
    Ariumi, H
    Migita, K
    Hori, N
    Hashiguchi, T
    Sakai, M
    Saeki, M
    Takano, Y
    Kamiya, HO
    NEUROSCIENCE LETTERS, 1998, 254 (03) : 169 - 172
  • [35] A pilot study to assess the effect of treatment with an NK-1 receptor antagonist on urge urinary incontinence symptoms
    Green, S.
    Bergner, D.
    Kaufman, J.
    Alon, A.
    Ianus, J.
    McNaughton, K.
    Tozzi, C.
    Reiss, T.
    NEUROUROLOGY AND URODYNAMICS, 2006, 25 (06) : 619 - 620
  • [36] IS THE SELECTIVE NONPEPTIDE NK-1 RECEPTOR ANTAGONIST CP96,345 A PERIPHERALLY ACTING ANALGESIC
    BERGE, OG
    STAHLBERG, M
    REGULATORY PEPTIDES, 1993, 46 (1-2) : 430 - 432
  • [37] A new class of antiemetics: the NK-1 receptor antagonists
    Bleiberg, H
    CURRENT OPINION IN ONCOLOGY, 2000, 12 (04) : 284 - 288
  • [38] Piperazinyl oxime ethers as NK-1 receptor antagonists
    van den Hoogenband, A
    van Maarseveen, JH
    McCreary, AC
    Mulder, AT
    van Scharrenburg, GJM
    van Stuivenberg, HH
    Zethof, TJJ
    Zijta, B
    Bakker, WII
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (04) : 1045 - 1048
  • [39] The involvement of NK-1 receptor in the behavioural effects of ethanol
    Pastor, R
    Font, L
    Hunt, SP
    De Felipe, C
    Miquel, M
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 : S20 - S20
  • [40] The NK-1 Receptor: A New Target in Cancer Therapy
    Munoz, Miguel
    Rosso, Marisa
    Covenas, Rafael
    CURRENT DRUG TARGETS, 2011, 12 (06) : 909 - 921